Approval · Notice of Compliance 5503 · 1994
SEREVENT: Notice of Compliance 5503
Issued October 25, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5503
- Date
- October 25, 1994
- Company
- Glaxo Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Bronchodilator
Products in this notice
Medicinal ingredients
- SALMETEROL XINAFOATE 25 MCG per ACT
- SALMETEROL XINAFOATE 50 MCG per PCK